权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

CALCIUM SIGNALING AND OVARIAN CANCER

钙信号传导与卵巢癌

基本信息

批准号：
6554346
负责人：
Karin D Rodland
金额：
$ 22.59万
依托单位：
BATTELLE PACIFIC NORTHWEST LABORATORIES
依托单位国家：
美国
项目类别：
财政年份：
1998
资助国家：
美国
起止时间：
1998-07-01 至 2004-04-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/6554346
关键词：
calcium binding protein calcium flux cell proliferation clinical research enzyme activity female gene induction /repression human genetic material tag human subject mitogen activated protein kinase neoplasm /cancer genetics ovary neoplasms phosphatidylinositol 3 kinase protein structure function protooncogene tissue /cell culture

项目摘要

Ovarian carcinoma is one of the leading causes of cancer death among women. The low survival for victims of ovarian cancer (less than 13 percent for stage III disease) reflect, in large part, the highly aggressive and metastatic character of ovarian adenocarcinomas. Despite the obvious seriousness of ovarian cancer, very little is known about the normal biology of the ovarian surface epithelial cells which give rise to the most malignant forms of ovarian carcinoma. Data presented in this proposal indicate that increased extracellular calcium exerts a significant proliferative effect on ovarian surface epithelial cells, as measured by both thymidine incorporation and cell growth curves. Ovarian surface epithelial cells express mRNA and protein for the recently cloned Calcium-sensing Receptor (CaR). This G-protein coupled receptor has been shown to be responsible for triggering parathormone release from parathyroid cells in response to elevated extracellular calcium. We have shown that the CaR in ovarian surface epithelial cells displays the same functional responses to extracellular calcium and other agonists (including gadolinium) as does the parathyroid CaR. Activation of the CaR in ovarian surface epithelial cells is associated with increases in tyrosine phosphorylation, increased activity of the mitogen-activated kinase ERK2, and increased src kinase activity. Expressing a non-functional mutant of the CaR (R796W) inhibited the increases in tyrosine phosphorylation and ERK2 activity observed in response to agonists of the CaR, indicating that the presence of functional CaR is required for these responses to increased extracellular calcium. Furthermore, we have observed that two of four ovarian tumor cell lines examined appear to over-express CaR mRNA, as well as expressing a novel CaR transcript. These ovarian tumor cell lines are no longer growth-inhibited in low calcium media. This proposal is based on the hypotheses that signal transduction downstream of the CaR leads directly to activation of ERK kinase and increased proliferation, and that disruption of normal CaR expression and/or function contributes to the loss of normal growth controls in ovarian carcinogenesis. These hypotheses will be tested by 1) disrupting known signaling mechanisms and observing the effect on CaR-dependent activation of src and/or ERK2, using transfection of dominant negative mutants or selective chemical inhibitors, 2) using a prospective study of CaR expression in patients with ovarian cancer to test clinical relevance.

卵巢癌是癌症死亡的主要原因之一，妇女卵巢癌患者的低生存率（低于13 第三阶段疾病的百分比）在很大程度上反映了卵巢腺癌的侵袭性和转移性。尽管卵巢癌的早期症状有哪些？卵巢表面上皮细胞的正常生物学，发展成最恶性的卵巢癌呈现的数据在该提议中，表明增加细胞外钙发挥对卵巢表面上皮细胞有显著的增殖作用，如通过胸苷掺入和细胞生长曲线测量的。卵巢表面上皮细胞表达与卵巢癌相关的mRNA和蛋白。钙敏感受体（CaR）。这种G蛋白已经证明一种受体负责触发甲状旁腺激素甲状旁腺细胞对升高的细胞外钙我们已经证明卵巢表面上皮细胞中的CaR 对细胞外钙离子表现出相同的功能反应，其他激动剂（包括钆），如甲状旁腺CaR。卵巢表面上皮细胞中CaR的激活与随着酪氨酸磷酸化的增加，丝裂原活化激酶ERK 2，并增加src激酶活性。表达CaR的无功能突变体（R796 W）抑制了细胞增殖。酪氨酸磷酸化和ERK 2活性增加，对CaR激动剂的反应，表明功能性CaR是这些反应所必需的，细胞外钙此外，我们还观察到，卵巢肿瘤细胞系检查似乎过表达CaR mRNA，并表达一种新的CaR转录本。这些卵巢肿瘤细胞品系在低钙培养基中不再受到生长抑制。这该建议是基于这样的假设，即下游信号转导直接导致ERK激酶的激活，增殖和正常CaR表达破坏，和/或功能导致卵巢中正常生长控制的丧失致癌作用这些假设将通过1）破坏已知的信号转导机制，观察对CaR依赖性 src和/或ERK 2的激活，使用显性阴性转染突变体或选择性化学抑制剂，2）使用前瞻性研究卵巢癌患者的CaR表达，以测试临床本案无关